Antigen | Vial size (doses/vial) | Doses administered (A) | Doses issued (B) | Vaccine usage rate C = (A/B) X 100 (%) | Vaccine wastage rate D = (100-C) (%) | Vaccine wastage rangea (D, %) | Wastage Factor E = 100/ (100-D) |
---|---|---|---|---|---|---|---|
Kangra | |||||||
 BCG | 10 | 33,741 | 53,614 | 62.9 | 37.1 | 5–83 | 1.6 |
 DPT | 10 | 87,325 | 128,532 | 67.9 | 32.1 | 5–80 | 1.5 |
 HBV | 10 | 3450 | 4952 | 69.7 | 30.3 | 5.5–70.6 | 1.4 |
 Measles | 5 | 45,747 | 67,459 | 67.8 | 32.2 | 0–81 | 1.5 |
 MR | 10 | 78,708 | 132,270 | 59.5 | 40.5 | 0–90 | 1.7 |
 OPV | 20 | 203,011 | 412,723 | 49.2 | 50.8 | 0–75 | 2.0 |
 PCV | 10 | 19,651 | 26,908 | 73.0 | 27.0 | 0–83 | 1.4 |
 LPV | 10 | 98,578 | 120,741 | 81.6 | 18.4 | 0–83 | 1.2 |
 TT | 10 | 32,599 | 49,480 | 65.9 | 34.1 | 4.8–76 | 1.5 |
 IPV | 10 | 13,142 | 20,553 | 63.9 | 36.1 | 0–77 | 1.6 |
 fIPV | 50 | 27,238 | 60,296 | 45.2 | 54.8 | 10–82 | 2.2 |
 IPV pooled | 10/50 | 40,380 | 80,849 | 49.9 | 50.1 | 0–82 | 2.0 |
 RVV-5 | 5 | 40,278 | 56,758 | 71.0 | 29.0 | 0–75 | 1.4 |
 RVV-10 | 10 | 73,107 | 109,516 | 66.8 | 33.2 | 0–82 | 1.5 |
 RVV pooled | 5/10 | 113,385 | 166,274 | 68.2 | 31.8 | 0–82 | 1.5 |
Pune | |||||||
 BCG | 10 | 12,121 | 18,664 | 64.9 | 35.1 | 0–87.5 | 1.5 |
 DPT | 10 | 13,884 | 18,603 | 74.6 | 25.4 | 0–78 | 1.3 |
 HBV | 10 | 7985 | 9955 | 80.2 | 19.8 | 6.6–80 | 1.2 |
 Measels | 5 | 22,313 | 28,506 | 78.3 | 21.7 | 0–75 | 1.3 |
 OPV | 20 | 80,787 | 94,308 | 85.7 | 14.3 | 0–74.3 | 1.2 |
 LPV | 10 | 36,432 | 41,985 | 86.8 | 13.2 | 0–78.6 | 1.2 |
 TT | 10 | 36,481 | 47,410 | 76.9 | 23.1 | 0–87.6 | 1.3 |
 IPV | 10 | 718 | 880 | 81.6 | 18.4 | 0–60 | 1.2 |
 fIPV | 50 | 5123 | 7010 | 73.1 | 26.9 | 9–76 | 1.4 |
 IPV pooled | 10/50 | 5841 | 7890 | 74.0 | 26.0 | 0–76 | 1.4 |
 RVV-5 | 5 | 10,335 | 12,570 | 82.2 | 17.8 | 0–88 | 1.2 |
 RVV-10 | 10 | 21,941 | 29,524 | 74.3 | 25.7 | 0–90 | 1.3 |
 RVV pooled | 5/10 | 32,276 | 42,094 | 76.7 | 23.3 | 0–90 | 1.3 |